Bay Area #1 in 2Q Funding

Home/Financial/Bay Area #1 in 2Q Funding

Bay Area #1 in 2Q Funding

The PwC/MoneyTree™ Life Sciences Report: Quarterly Q2 2015 is out, and the San Francisco Bay Area led all regions in the most life sciences venture capital dollars ($1.3 billion), with $926 million going to biotechnology and the remaining $377 million going to medical devices.

fMore from the report:

“VC investments in biotechnology benefited from a few large biotechnology deals: Denali Therapeutics Inc. ($217 million), Aduro BioTech Inc ($200 million) and Adaptive Biotechnologies ($195.1 million).The medical device industry also increased by 22% in terms of dollars, but deal volume decreased by 3% for the first quarter of 2015, capturing $814 million in 75 deals, compared with the same quarter last year.

“In the second quarter early stage investments grew significantly year-over-year for both biotechnology and medical devices,” said Greg Vlahos, Life Sciences Partner at PwC, “It’s another sign of confidence in the sector.”

Full report

August 27th, 2015|